Abstract
ObjectivesTo conduct an updated overall safety analysis of rituximab (RTX) in RA patients in the global clinical trial programme.MethodsPooled observed case analysis of safety data from patients with moderate to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
